Analysts name 2 fantastic ASX 200 shares to buy

Here are two ASX 200 shares analysts rate highly…

The S&P/ASX 200 Index (ASX: XJO) is home to a large number of quality companies with the potential to generate strong returns for investors in the future.

Two that analysts are particularly positive on are listed below. Here's why they are tipping them as buys right now:

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices.

Image source: Getty Images

Breville Group Ltd (ASX: BRG)

The first ASX 200 share to look at is Breville. is one of the world's leading appliance manufacturers. As well as the eponymous Breville brand, it also has the Sage, Kambrook, and Baratza brands.

Breville has been growing at a consistently solid rate for the last decade and looks well-placed to continue this trend over the next decade. This is thanks to the popularity of its brands, its international expansion, acquisitions, favourable consumer trends, and its continued investment in R&D.

Macquarie is very positive on the company's future and expects further strong growth in the coming years. Last week its analysts retained their outperform rating and $34.37 price target on the company's shares. The broker notes that rival DeLonghi and one of Breville's distributors in the US recently reported strong results. It feels this bodes well for Breville's performance.

ResMed Inc. (ASX: RMD)

Another ASX 200 share that could be a top option is ResMed. It is a medical device company with a focus on the sleep treatment market.

Thanks to its industry-leading products, wide distribution network, and successful acquisitions, ResMed has been growing at a very strong rate over the last few years.

The good news is that thanks to its significant market opportunity, the growing prevalence of sleep disorders, and new product launches, it has been tipped to continue doing so for the foreseeable future. In addition, ResMed's near term performance is being boosted by a major product recall from rival Philips.

Morgans is a fan of ResMed. Its analysts currently have an add rating and $40.80 price target on its shares. The broker believes ResMed is well-placed as it builds a unique, patient-centric, connected-care digital platform that addresses the main pinch points across the healthcare value chain.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

Happy investor on tablet with finance graphs rising in overlay.
Growth Shares

Could these 3 ASX shares grow into $100 billion companies by 2036?

I wouldn't rule out any of these three companies reaching this milestone, although I'd be much more confident backing one…

Read more »

Two men sit side by side on a couch with video game controls in their hands and expressive looks on their faces.
Growth Shares

3 ASX growth shares almost as exciting as the GTA 6 release

It is a great time to be a gamer. But are these shares just as exciting?

Read more »

Happy young couple riding a motorbike together.
Growth Shares

3 ASX shares I think could be worth twice as much in 5 years

These shares appear well-placed for growth over the next half-decade.

Read more »

Happy businessman fist pumping while looking at a tablet.
Growth Shares

Why WiseTech and these ASX growth shares make my shortlist for 2027

There are reasons to be positive on these growing companies.

Read more »

Man looking happy and excited as he looks at his mobile phone.
Growth Shares

Could this ASX 200 share turn $10,000 into $20,000 by 2030?

The company already has an impressive global presence, but I think there's still plenty of room to grow.

Read more »

Two shop workers smiling and looking at a laptop surrounded by plants.
Growth Shares

The ASX's next great growth stock? I've narrowed my shortlist to two

These companies have already made impressive progress, but I think there's still a lot more they could achieve.

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Growth Shares

2 ASX shares highly recommended to buy: Experts

Multiple brokers are excited about these ideas.

Read more »

A couple sits on the bed in their hotel room wearing white robes, with both having seen bad news on their phones.
Growth Shares

A rare buying opportunity in 1 of Australia's top shares?

This business is delivering significant financial growth.

Read more »